Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0140-6736(76)93140-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthetic somatostatin analogs beyond cancer.
Pituitary
December 2024
Medical University of Lodz, Lodz, Poland.
Octreotide-LAR in ADPKD patients with very low kidney function: a single-center real-life experience.
J Nephrol
December 2024
Chair of Nephrology, Department of Public Health, Federico II University, Naples, Italy.
Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.
Am J Ther
September 2024
Division of Gastroenterology and Hepatology, University of Missouri Kansas City, Kansas City, MO.
Bibliometric analysis of studies of somatostatin in the treatment of severe pancreatitis.
Asian J Surg
August 2024
Department of Hepatobiliary and Pancreatic Surgery, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, Jiujiang, China. Electronic address:
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience.
Pituitary
June 2024
Dipartimento di Medicina e Chirurgia traslazionale, Università Cattolica del Sacro Cuore, Largo A. Gemelli, Rome, Italy.
Introduction: Skeletal fragility is a clinically relevant and not-reversible complication of acromegaly, involving around 30-40% of patients since the disease diagnosis. Few studies have investigated the effects on skeletal health of medical therapies for acromegaly. In this retrospective longitudinal monocentre study, we investigated the outcome of skeletal fragility in patients treated with Pasireotide Lar in combination with Pegvisomant (Pasi-Lar + Peg-V), also comparing those observed in patients treated with conventional therapies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!